February 11, 2018 / 1:49 PM / Updated 7 hours ago

BRIEF-Shenzhen Hepalink Pharmaceutical Plans JV With U.S. firm Aridis Pharmaceuticals

Reuters Staff

1 Min Read

Feb 11 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :

* SAYS IT PLANS TO SET UP JV WITH CALIFORNIA'S ARIDIS PHARMACEUTICALS INC Source text in Chinese: bit.ly/2EWE579 Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.